MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5935/abc.20130168

Медицинская библиотека · Arquivos brasileiros de cardiologia · 2013

Pulmonary arterial hypertension: use of delayed contrast-enhanced cardiovascular magnetic resonance in risk assessment.

Bessa Luiz Gustavo Pignataro, Junqueira Flávia Pegado, Bandeira Marcelo Luiz da Silva, Garcia Marcelo Iorio, Xavier Sérgio Salles, Lavall Guilherme, Torres Diego, Waetge Daniel

Оценочное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Pulmonary arterial hypertension is a severe and progressive disease. Its early diagnosis is the greatest clinical challenge.

OBJECTIVE

To evaluate the presence and extension of the delayed myocardial contrast-enhanced cardiovascular magnetic resonance, as well as to verify if the percentage of the myocardial fibrosis mass is a severity predictor.

METHODS

Cross-sectional study with 30 patients with pulmonary arterial hypertension of groups I and IV, subjected to clinical, functional and hemodynamic evaluation, and to cardiac magnetic resonance.

RESULTS

The mean age of patients was 52 years old, with female predominance (77%). Among the patients, 53% had right ventricular failure at diagnosis, and 90% were in functional class II/III. The mean of the 6-minute walk test was 395 m. In hemodynamic study with right catheterism, the mean average pulmonary arterial pressure was 53.3 mmHg, of the cardiac index of 2.1 L/min.m(2), and median right atrial pressure was 13.5 mmHg. Delayed myocardial contrast-enhanced cardiovascular magnetic resonance was found in 28 patients. The mean fibrosis mass was 9.9 g and the median percentage of fibrosis mass was 6.17%. The presence of functional class IV, right ventricular failure at diagnosis, 6-minute walk test < 300 meters and right atrial pressure > 15 mmHg, with cardiac index < 2.0 L/min.m(2), there was a relevant association with the increased percentage of myocardial fibrosis.

CONCLUSION

The percentage of the myocardial fibrosis mass indicates a non-invasive marker with promising perspectives in identifying patients with high risk factors for pulmonary hypertension.

Для цитирования: Bessa Luiz Gustavo Pignataro, Junqueira Flávia Pegado, Bandeira Marcelo Luiz da Silva, Garcia Marcelo Iorio, Xavier Sérgio Salles, Lavall Guilherme, Torres Diego, Waetge Daniel. Pulmonary arterial hypertension: use of delayed contrast-enhanced cardiovascular magnetic resonance in risk assessment.. Arquivos brasileiros de cardiologia. 2013. DOI: 10.5935/abc.20130168.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.